Graeme Greenfield

ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 7

Top Venues

BMC hematology

Cancers

Journal of clinical pathology

Journal of hematology & oncology

Queen's University Belfast

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queen's University Belfast Jul 19 2019

United Kingdom

ICAT Fellow :: Centre for Cancer Research and Cell Biology

Queen's University Belfast Aug 02 2017 - Aug 06 2019

United Kingdom

Academic Clinical Fellow :: Centre for Cancer Research and Cell Biology

Publications

Graeme Greenfield, Mary Frances McMullin, Ken Mills
Molecular pathogenesis of the myeloproliferative neoplasms. Journal of hematology & oncology 14 (1) (2021)
Olga Michail, Patrick McCallion, Julie McGimpsey, Andrew Hindley, Graeme Greenfield, Roisin McAllister, John Feerick, Claire Arnold, Nick Cross, Robert Cuthbert, Mary Frances Frances McMullin, Mark Alexander Catherwood
Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort. Journal of clinical pathology 74 (12) (2020)
Graeme Greenfield, Suzanne McPherson, James Smith, Adam Mead, Claire Harrison, Ken Mills, Mary Frances Frances McMullin
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms. Cancers 12 (9) (2020)
Graeme Greenfield, Ross McMullan, Nuala Robson, Julie McGimpsey, Mark Catherwood, Mary Frances McMullin
Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia. BMC hematology 19 (2019)
Graeme Greenfield, Mary Frances McMullin
Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series. Thrombosis journal 16 (2018)
Graeme Greenfield, Olga Michail, Bridgin Merron, Julie McGimpsey, Mark Alexander Catherwood, Mary Frances Frances McMullin
Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation. British journal of haematology 186 (1) (2018)
Graeme Greenfield, Suzanne McPherson, Ken Mills, Mary Frances McMullin
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms. Journal of translational medicine 16 (1) (2018)

Graeme Greenfield.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Graeme Greenfield